Invitrogen™ VLDLR Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5116116

Catalog No. PIPA5116116

Description

Antibody detects endogenous levels of total VLDL Receptor.

The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene.

Specifications

• Antigen: VLDLR
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: VLDLR
• Gene Alias: AA408956; AI451093; AW047288; CAMRQ1; CARMQ1; CHRMQ1; FLJ35024; non O-glycosylated VLDL-R; very low density lipoprotein receptor; very low density lipoprotein receptor VLDL-R2; very low-density lipoprotein receptor; VLDL receptor; VLDLR; VLDL-R; VLDLRCH
• Host Species: Rabbit
• Purification Method: Affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 22359, 25696, 7436
• Content And Storage: -20°C
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin), Western Blot
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide
• Gene Accession No.: P98155, P98156, P98166
• Gene Symbols: VLDLR
• Immunogen: A synthesized peptide derived from human VLDLR(Accession P98155), corresponding to amino acid residues A122-V172.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Mouse, Rat
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov